Pliwa’s GMP certification: A strategic asset for Christeyns

Pliwa, a Christeyns company, has successfully completed a rigorous GMP inspection, thereby renewing its certification as a GMP-compliant production facility. The audit is renowned for its thoroughness and strict regulatory requirements, and the outcome was exceptionally positive. This result is the fruit of years of continuous improvement and a culture of quality deeply rooted throughout the organisation, achieved through dedication and hard work.
But why is this achievement important?
GMP (Good Manufacturing Practice) standards are typically only found in pharmaceutical-grade production. GMP certification is therefore demanding and uncommon in the hygiene industry.
Pharmaceutical companies typically select suppliers who can:
– minimise the risk of contamination
– ensure consistent and reproducible quality
– provide robust and transparent documentation.

A GMP-certified hygiene products supplier offers clear benefits to demanding industries, including greater confidence, lower supplier-related risk, and strong regulatory alignment.
Pharmaceutical customers value suppliers who truly ‘speak the same language’ in terms of quality systems and compliance expectations.
However, most manufacturers of hygiene chemicals do not operate at this level, as GMP compliance often exceeds the requirements of industrial production — even for the manufacture of medical devices.
GMP certification for hygiene products supplied to the pharmaceutical sector is a key differentiator for Christeyns, representing a decisive strategic advantage.
This recertification is not merely an operational achievement — it is a strategic milestone that will support Christeyns’ continued growth in higher-regulated markets.